C5a



C5a

T1TT1L2LL2Q3QQ3K4KK4K5KK5I6II6E7EE7E8EE8I9II9A10AA10A11AA11K12KK12Y13YY13K14KK14H15HH15S16SS16V17VV17V18VV18K19KK19K20KK20C21CC21C22CC22Y23YY23D24DD24G25GG25A26AA26C27CC27V28VV28N29NN29N30NN30D31DD31E32EE32T33TT33C34CC34E35EE35Q36QQ36R37RR37A38AA38A39AA39R40RR40I41II41S42SS42L43LL43G44GG44P45PP45R46RR46C47CC47... and 27 more residue(s)...... and 27 more residue(s)

SMILES None
InChIKey None
Sequence TLQKKIEEIAAKYKHSVVKKCCYDGACVNNDETCEQRAARISLGPRCIKAFTECCVVASQLRANISHKDMQLGR

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Structure pdb 8HK5 8HQC 8IA2

No bioactivity data available.

C5a

T1TT1L2LL2Q3QQ3K4KK4K5KK5I6II6E7EE7E8EE8I9II9A10AA10A11AA11K12KK12Y13YY13K14KK14H15HH15S16SS16V17VV17V18VV18K19KK19K20KK20C21CC21C22CC22Y23YY23D24DD24G25GG25A26AA26C27CC27V28VV28N29NN29N30NN30D31DD31E32EE32T33TT33C34CC34E35EE35Q36QQ36R37RR37A38AA38A39AA39R40RR40I41II41S42SS42L43LL43G44GG44P45PP45R46RR46C47CC47... and 27 more residue(s)...... and 27 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 8HK5 8HQC 8IA2

Compound is not listed as a drug.